Evidence map›Paper›PMID 23162682›Full record

ArticleJRSM short reports2012

Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study.

Hugh Ip, Tarik Amer, Michael Dangoor, Affan Zamir, Darryl Gibbings-Isaac, Ranjeev Kochhar, Timothy Heymann

Abstract read
In one paragraph

Article in JRSM short reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hugh IpGuy's and St Thomas' NHS Foundation Trust , London SE1 7EH , UK.
Tarik Amer
Michael Dangoor
Affan Zamir
Darryl Gibbings-Isaac
Ranjeev Kochhar
Timothy Heymann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEngland's National Health Service (NHS) introduced a 62-day target, from referral to treatment, to make lung cancer patient pathways more efficient. This study aims to understand pathway delays that lead to breaches of the target when patients need care in both secondary and tertiary setting, so more than one institution is involved.

designMixed methods cross case analysis.

settingTwo tertiary referral hospitals in London.

participantsDatabase records of 53 patients were analysed. Nineteen sets of patient notes were used for pathway mapping. Seventeen doctors, four nurses, eight managers and administrators were interviewed.

main outcome measuresQualitative methods include pathway mapping and semi-structured interviews. Quantitative analysis of patient pathway times from cancer services records.

resultsThe majority of the patient pathway (68.4%) is spent in secondary centres. There is more variability in the processes of secondary centres but tertiary centres do not have perfect processes either. Three themes emerged from discussions: information flows, pathway performance and the role of the multidisciplinary approach.

conclusionsThe actions of secondary centres have a greater influence on whether a patient breaches the 62-day target, compared with tertiary centres. Nevertheless variability exists in both, with potential for improvement.

Identifiers

PMID23162682
PMCPMC3499958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.